Presbyopia
307
18
27
208
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
116 trials with published results (38%)
Research Maturity
208 completed trials (68% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
5.2%
16 terminated out of 307 trials
92.9%
+6.3% vs benchmark
13%
41 trials in Phase 3/4
56%
116 of 208 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 208 completed trials
Clinical Trials (307)
A New Successful Approach for Emmetropic Presbyopic Patients Using Intrastromal Pocket With Smile Module
Evaluate the Efficacy and Safety of CTO0307 in Adults With Presbyopia
Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia
Contralateral Claims Study of Clareon Vivity Pro
Comparison of PRESBYOND Laser Blended Vision and Conventional Monovision LASIK in Individuals With Presbyopia: A Randomized Clinical Study
Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses
Proof-of-Concept for a Novel Optical Aperture Contact Lens in Presbyopia and Keratoconus
Refitting Satisfied INFUSE One-Day Multifocal Wearers to DAILIES TOTAL1 Multifocal Contact Lenses
VisionApp - Refraction and Presbyopia
Refocus VisAbility™ Micro Insert System Pre-market Clinical Trial
CorVision® 4-year Follow-up
Clareon PanOptix Pro vs. Clareon PanOptix - Study B
Volumetric Visual Fields at Intermediate and Near Distances in Presbyopic Patients Using Occupational and General-Purpose Progressive Addition Lenses
Clinical Study to Investigate Outcomes of Trifocal Toric IOL POD FT in Asian Eyes
Contact Lens Trial Fitting Experience
Clinical Performance of Verofilcon A Toric Contact Lenses
Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia
Phase 3 Safety Study of LNZ100 and LNZ101 for the Treatment of Presbyopia Subjects
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add